Phenominer Database Results (12 results)

 

How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Site Method Duration Post Insult Time Value Record ID Study ID
BB.SHR-(Gnal-D18Mit9)/K blood CD45RC(high) CD4 T cell count to CD45RC(low) CD4 T cell count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. CD4-positive T cell quantity both 90 days 14 0.08 % 0.01 0.03 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 84690 324
BB.SHR-(Gnal-D18Mit9)/K blood natural killer cell count to total lymphocyte count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. natural killer cell quantity both 90 days 14 13.8 % 1.34 5.0 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 84633 324
BB.SHR-(Gnal-D18Mit9)/K blood CD25 lymphocyte count to total lymphocyte count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. lymphocyte quantity both 90 days 14 70.5 % 1.36 5.1 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 84639 324
BB.SHR-(Gnal-D18Mit9)/K blood CD45RC(low) CD4 T lymphocyte count to total lymphocyte count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. CD4-positive T cell quantity both 90 days 14 65.9 % 1.76 6.6 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 84687 324
BB.SHR-(Gnal-D18Mit9)/K blood RT6.1 positive cell count to total lymphocyte count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. T cell quantity both 90 days 14 3.4 % 0.67 2.5 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 84636 324
BB.SHR-(Gnal-D18Mit9)/K blood CD4 lymphocyte count to total lymphocyte count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. CD4-positive T cell quantity both 90 days 14 34.1 % 2.14 8.0 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 84627 324
BB.SHR-(Gnal-D18Mit9)/K blood T lymphocyte count to total leukocyte count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. T cell quantity both 90 days 14 11.8 % 0.78 2.9 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 75603 324
BB.SHR-(Gnal-D18Mit9)/K blood CD8 lymphocyte count to total lymphocyte count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. CD8-positive T cell quantity both 90 days 14 0.6 % 0.08 0.3 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 84630 324
BB.SHR-(Gnal-D18Mit9)/K blood lymphocyte count control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. lymphocyte quantity both 90 days 14 2.0 x 1000 cells/ul 0.17 0.63 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 75597 324
BB.SHR-(Gnal-D18Mit9)/K blood B lymphocyte count to total leukocyte count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. B cell quantity both 90 days 14 37.4 % 2.75 10.3 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 75600 324
BB.SHR-(Gnal-D18Mit9)/K white blood cell count control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. leukocyte quantity both 90 days 14 2.83 x 1000 cells/ul 0.23 0.87 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 75606 324
BB.SHR-(Gnal-D18Mit9)/K blood CD45RC(high) CD4 T lymphocyte count to total lymphocyte count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. CD4-positive T cell quantity both 90 days 14 4.8 % 0.43 1.6 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 84684 324